Dr. Merzkani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-362-7603Fax+1 314-362-5470
Education & Training
- Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 2012 - 2015
- Universidad Nacional Autonoma de Honduras Class of 2011
Certifications & Licensure
- IL State Medical License 2021 - 2026
- MN State Medical License 2017 - 2025
- MO State Medical License 2020 - 2025
- NY State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Allosure in Simultaneous Pancreas Kidney Transplant Start of enrollment: 2021 Feb 26
Roles: Contact
Publications & Presentations
PubMed
- 8 citationsAssociation of Ambient Fine Particulate Matter Air Pollution With Kidney Transplant Outcomes.Su-Hsin Chang, Massini Merzkani, Haris Murad, Mei Wang, Benjamin Bowe
JAMA Network Open. 2021-10-01 - 33 citationsThe Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients.Aleksandra Kukla, Jennifer Hill, Massini A. Merzkani, Andrew Bentall, Elizabeth C. Lorenz
Transplantation Direct. 2020-01-13 - 9 citationsBone marrow derived long-lived plasma cell phenotypes are heterogeneous and can change in culture.Syed S Mujtahedi, Furkan Yigitbilek, Xiomara Benavides, Massini A Merzkani, Elif Ozdogan
Transplant Immunology. 2022-12-01
Press Mentions
- New Research Shows Markers in Donor Kidneys That Could Reduce RisksNovember 12th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: